SCHEMBL8843383

SCHEMBL8843383

COc1cc(C(=C(C(=O)O)P(=O)(OC)OC)C(C)C)ccc1O

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.52
KMT2A Q03164 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
RAB9A P51151 1/20 0.50
BLM P54132 2/20 0.46
CYP1A2 P05177 1/20 0.46
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
HSD17B2 P37059 1/20 0.44
AURKB Q96GD4 1/20 0.43
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TSHR P16473 1/20 0.42
GCGR P47871 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2208985 0.77 HTT (0.56) HTTKMT2ASLC22A6SLC22A8MEN1
SCHEMBL6835992 0.73 MEN1 (0.68) HTTKMT2ASLC22A6SLC22A8MEN1
Apocynin SCHEMBL27893253 0.72 HTT (0.65) HTTKMT2ASLC22A6SLC22A8MEN1
SCHEMBL30921173 0.71 MEN1 (0.82) HTTKMT2ASLC22A6SLC22A8MEN1
Vanillic Acid SCHEMBL11238609 0.71 HTT (0.93) HTTKMT2ASLC22A6SLC22A8MEN1
SCHEMBL760262 0.71 MEN1 (0.82) HTTKMT2ASLC22A6SLC22A8MEN1
Vanillic Acid SCHEMBL26179 0.70 HTT (1.00) HTTKMT2ASLC22A6SLC22A8MEN1
Vanillic Acid SCHEMBL29378740 0.70 HTT (1.00) HTTKMT2ASLC22A6SLC22A8MEN1
Vanillic Acid SCHEMBL9711598 0.70 HTT (1.00) HTTKMT2ASLC22A6SLC22A8MEN1
Apocynin SCHEMBL28537029 0.70 HTT (0.71) HTTKMT2ASLC22A6SLC22A8MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5627173-A Phosphonoacetic acid derivatives and their use for treating degenerative joint disorders HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-06 US disclosed